Positives CHMP-Votum für CTLA-4-Inhibitor bei Patienten ab 12 Jahren
Crossref DOI link: https://doi.org/10.1007/s15015-018-3809-1
Published Online: 2018-02-05
Published Print: 2018-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
red,
Text and Data Mining valid from 2018-02-01
Article History
First Online: 5 February 2018